Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers and data scientists at IBM have developed three novel algorithms aimed at uncovering the underlying biological processes that cause tumors to form and grow.
Walgreens store associates and managers across the U.S. will soon be equipped with small, AI-powered devices that will allow them to remain “heads-up and hands-free” while communicating among themselves to help customers.
Compared with standard statistical reviews of process-control charts, AI analysis of data routinely captured by hospitals monitoring handwashing compliance can provide highly targeted and actionable feedback to individual healthcare workers.
Medical-device giant Medtronic is partnering with Viz.ai to offer stroke centers capabilities for automatically flagging large vessel occlusions while the patient is still on the bed of a CT scanner.
Combining machine learning with statistical modeling, researchers have analyzed tweets to figure out who’s doing more to keep fit—men or women—along with exactly how the sexes are exercising and approximately where they live.
In regions of the world lacking resources to conduct comprehensive autopsies, AI can automatically draw cause-of-death conclusions from verbalized clues.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.